These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20356579)

  • 1. Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice.
    Pelletier L; Baillargeon JP
    Fertil Steril; 2010 Dec; 94(7):2665-9. PubMed ID: 20356579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome.
    Saleh AM; Khalil HS
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):614-21. PubMed ID: 15225184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
    Moran LJ; Pasquali R; Teede HJ; Hoeger KM; Norman RJ
    Fertil Steril; 2009 Dec; 92(6):1966-82. PubMed ID: 19062007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome.
    van Dam EW; Roelfsema F; Veldhuis JD; Hogendoorn S; Westenberg J; Helmerhorst FM; Frölich M; Krans HM; Meinders AE; Pijl H
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E615-20. PubMed ID: 14678951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.
    Alvarez-Blasco F; Botella-Carretero JI; San Millán JL; Escobar-Morreale HF
    Arch Intern Med; 2006 Oct; 166(19):2081-6. PubMed ID: 17060537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome.
    Stamets K; Taylor DS; Kunselman A; Demers LM; Pelkman CL; Legro RS
    Fertil Steril; 2004 Mar; 81(3):630-7. PubMed ID: 15037413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The polycystic ovary syndrome and increased body mass].
    Alieva EA; Fanchenko ND; Pshenichnikova TIa; Parshutin NP; Gasparov AS; Vetr M
    Acta Univ Palacki Olomuc Fac Med; 1990; 126():233-40. PubMed ID: 2151090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of polycystic ovary syndrome in women with type 2 diabetes in Kerman, Iran.
    Mirzaei F; Kazemi N
    Metab Syndr Relat Disord; 2008 Sep; 6(3):215-7. PubMed ID: 18710333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic infertility including polycystic ovary syndrome.
    Brassard M; AinMelk Y; Baillargeon JP
    Med Clin North Am; 2008 Sep; 92(5):1163-92, xi. PubMed ID: 18721657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
    Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
    Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome in the United States: clinical visit rates, characteristics, and associated health care costs.
    Jason J
    Arch Intern Med; 2011 Jul; 171(13):1209-11. PubMed ID: 21747019
    [No Abstract]   [Full Text] [Related]  

  • 14. Obesity and PCOS: implications for diagnosis and treatment.
    Legro RS
    Semin Reprod Med; 2012 Dec; 30(6):496-506. PubMed ID: 23074008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise therapy in polycystic ovary syndrome.
    Hoeger KM
    Semin Reprod Med; 2008 Jan; 26(1):93-100. PubMed ID: 18181087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
    Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
    Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome in the adolescent.
    Pfeifer SM; Kives S
    Obstet Gynecol Clin North Am; 2009 Mar; 36(1):129-52. PubMed ID: 19344852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lifestyle modification in the management of polycystic ovary syndrome.
    Hoeger KM
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polycystic ovary syndrome I. Clinical presentation and treatment].
    Ovesen PG; Møller N; Greisen S; Ingerslev HJ
    Ugeskr Laeger; 1998 Jan; 160(3):260-4. PubMed ID: 9454393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.